Wein Matthew sold MGX
December 5, 2025 · Form 4 insider transaction
Wein Matthew sold 199 shares of Metagenomi Therapeutics, Inc. at $1.77 per share, a transaction worth $352.61. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 3 days after the transaction.
Direction
Disposed (sell-side)
Shares
199
Price
$1.77
Total value
$352.61
InsiderWein Matthew
RoleOfficer
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateDecember 5, 2025
Filing dateDecember 8, 2025
Shares owned after115,031
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
These shares of common stock were automatically sold for the purpose of satisfying the Reporting Person's tax withholding obligations upon the vesting of certain restricted stock units granted to the Reporting Person on April 1, 2024, and does not represent a volitional trade by the Reporting Person.